Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation*
暂无分享,去创建一个
F. Gonzalez | M. Tohkin | M. Miyata | J. Bend | F J Gonzalez | K Nagata | K. Nagata | M Tohkin | M Miyata | C J Sinal | J R Bend | C. Sinal
[1] J. Falck,et al. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. , 2000, Journal of lipid research.
[2] F. Oesch,et al. Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds. , 1987, Biochemical pharmacology.
[3] A. Katz,et al. Intracellular signaling in the regulation of renal Na-K-ATPase. II. Role of eicosanoids. , 1993, The Journal of clinical investigation.
[4] W. Campbell. New role for epoxyeicosatrienoic acids as anti-inflammatory mediators. , 2000, Trends in pharmacological sciences.
[5] H. Jacobson,et al. Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. , 1992, The Journal of biological chemistry.
[6] D. Christianson,et al. Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[7] L. Navar,et al. Actions of epoxygenase metabolites on the preglomerular vasculature. , 1996, Journal of the American Society of Nephrology : JASN.
[8] K. Fujiwara,et al. Involvement of pituitary hormone in the sex-related regulation of hepatic epoxide hydrolase activity in mice. , 1991, Biological & pharmaceutical bulletin.
[9] D. Kroetz,et al. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney. , 2000, Molecular pharmacology.
[10] F. Gonzalez,et al. Targeted Disruption of the Microsomal Epoxide Hydrolase Gene , 1999, The Journal of Biological Chemistry.
[11] B. Hammock,et al. Spectrophotometric assay for mammalian cytosolic epoxide hydrolase using trans-stilbene oxide as the substrate. , 1982, Biochemical pharmacology.
[12] M. Romero,et al. An epoxygenase metabolite of arachidonic acid 5,6 epoxy-eicosatrienoic acid mediates angiotensin-induced natriuresis in proximal tubular epithelium. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.
[13] A. Katz,et al. Regulation of Na-K-ATPase Activity in the Proximal Tubule: Role of the Protein Kinase C Pathway and of Eicosanoids , 1996, The Journal of Membrane Biology.
[14] H. Jacob,et al. Renal cytochrome P4504A activity and salt sensitivity in spontaneously hypertensive rats. , 1996, Hypertension.
[15] J P Rapp,et al. Dahl salt-susceptible and salt-resistant rats. A review. , 1982, Hypertension.
[16] B. Hammock,et al. Molecular cloning and expression of murine liver soluble epoxide hydrolase. , 1993, The Journal of biological chemistry.
[17] B. Hammock,et al. Hydration of cis- and trans-epoxymethyl stearates by the cytosolic epoxide hydrase of mouse liver. , 1979, Biochemical and biophysical research communications.
[18] J. Bend,et al. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids. , 1994, Molecular pharmacology.
[19] H. Jacobson,et al. Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct. , 1989, The Journal of clinical investigation.
[20] O'Banion Mk. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. , 1999 .
[21] B. Hammock,et al. Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice. , 1995, Biochemical pharmacology.
[22] J. Satriano,et al. Angiotensin II stimulates phospholipases C and A2 in cultured rat mesangial cells. , 1987, The American journal of physiology.
[23] J. Falck,et al. Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. , 1993, The Journal of biological chemistry.
[24] H. Kim,et al. Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. , 1993, European journal of pharmacology.
[25] J. Rokach,et al. Leukotrienes, lipoxins, and hydroxyeicosatetraenoic acids. , 1999, Methods in molecular biology.
[26] J. Mcgiff,et al. Renal cytochrome P450-dependent eicosanoids. , 1997, Advances in experimental medicine and biology.
[27] D. Zeldin,et al. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. , 1993, The Journal of biological chemistry.
[28] K. Tomer,et al. Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. , 1996, Archives of biochemistry and biophysics.
[29] B. Borhan,et al. Development of an in situ toxicity assay system using recombinant baculoviruses. , 1996, Biochemical pharmacology.
[30] M. Seeds,et al. Regulation and metabolism of arachidonic acid , 1999, Clinical reviews in allergy & immunology.
[31] H. Jacobson,et al. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. , 1994, The Journal of clinical investigation.
[32] B D Hammock,et al. Potent urea and carbamate inhibitors of soluble epoxide hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[33] B. Borhan,et al. Improved radiolabeled substrates for soluble epoxide hydrolase. , 1995, Analytical biochemistry.
[34] B. Hammock,et al. Effect of dietary clofibrate on epoxide hydrolase activity in tissues of mice. , 1985, Biochemical pharmacology.
[35] G. FitzGerald,et al. Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. , 1990, Proceedings of the National Academy of Sciences of the United States of America.